Medical News Today (Free subscription) | yesterday
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.
The Many Thoughts of HarleyGirl (Free subscription) | yesterday
Well now that the worst of it is hopefully over I feel better about writing about what is going on with me. I was diagnosed with a rare form of leukemia called "Hairy Cell". Yes, that is really what it is called. Only 2 in 2 million women get this and I was the lucky one. I've been in the hospital since Oct 19th. I've had my chemotherapy. It was 7 days long, 24 hours a day. I'm waiting now...
Celebrity Gossip (Free subscription) | 11/07/2009
Talking about the role, Kelly said, “A few of the girls in the cast are more game than others to go nude.” The stage debut comes after a an intimate dinner at London restaurant J Sheekeys with boyfriend Danny Cipriani the previous evening. The cute couple recently moved in together, with Kelly telling, “It is only in the last few months that we have become an [official] couple and...
The Huffington Post (Free subscription) | 11/06/2009
As part of its Bearing Witness 2.0 project, the Huffington Post is rounding up a few of the best local stories of the day. Urangoo Baatarkhuyag, a Mongolian immigrant who moved to the United States eight years ago, has been told she will die because she does not have health insurance, reports Jed Boal for local NBC affiliate KSL . Baatarkhuyag, 24, was diagnosed with acute myeloid leukemia in September,...
PR News Wire (Free subscription) | 11/06/2009
WHITE PLAINS, N.Y., Nov. 6 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) will again be participating in Gap Inc.'s Give & Get program, which in its first two campaigns this past spring and summer, garnered more than $1 million to support LLS's blood cancer research funding and patient education and support services.
Fiercebiotech (Free subscription) | 11/06/2009
Bethesda, MD-based Micromet has agreed to buy out MedImmune's North American rights to blinatumomab , a potential treatment for lymphoma and leukemia. As a result of the buyout, Micromet now controls global rights to develop and commercialize blinatumomab and any other BiTE antibodies for hematological cancers. The companies inked the blinatumomab agreement in 2003 and planned to create up to six...
Medical News Today (Free subscription) | 11/06/2009
Cephalon, Inc. (Nasdaq: CEPH) announced the journal Cancer has published a pivotal study demonstrating that TREANDA® (bendamustine HCl) for Injection induced durable responses in patients with indolent B-cell non-Hodgkin's lymphoma (NHL) whose disease had progressed during or within six months of treatment with rituximab.
Medical News Today (Free subscription) | 11/06/2009
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML).
Medical News Today (Free subscription) | 11/06/2009
Stem Cell Therapy International Inc. (OTCBB: SCII) and its soon to be subsidiary, Histostem Ltd. of South Korea ("Histostem"), announced that they recently supplied hematopoietic stem cells to The Queen Mary Hospital of the University of Hong Kong, China, for treatment of Leukemia patients.
Medical News Today (Free subscription) | 11/06/2009
New data published today in the journal, Cancer, reveals that three quarters (75%) of patients with indolent B-cell non-Hodgkin's lymphoma (iNHL), responded to treatment with Bendamustine following a single-arm, multicentre study. Significantly, all patients participating in the study had become resistant or were unresponsive to rituximab (the standard treatment for the disease) when used either as...
The East Bay Business Times (Free subscription) | 11/05/2009
Sunesis Pharmaceuticals Inc. said Thursday the U.S. Food and Drug Administration granted orphan drug designation for voreloxin, its treatment of acute myeloid leukemia. (SNSS)
PLoS ONE (Free subscription) | 11/05/2009
Acute myeloid leukemia (AML) is a clonal disease originating from myeloid progenitor cells with a heterogeneous genetic background. High-dose cytarabine is used as the standard consolidation chemotherapy. Oncogenic RAS mutations are frequently observed in AML, and are associated with beneficial response to cytarabine. Why AML-patients with oncogenic RAS benefit most from high-dose cytarabine post-remission...
Science Daily (Free subscription) | 11/05/2009
For the first time, researchers have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.
Medical News Today (Free subscription) | 11/03/2009
Alexandra Wilson was just 4 when she was diagnosed with acute lymphocytic leukemia, a cancer affecting blood and blood marrow. Eleven years after completing treatment at Children's Medical Center Dallas she experienced heart abnormalities as a result of her chemotherapy. The sophomore at UT Dallas now receives her follow-up treatment at UT Southwestern Medical Center.
Physorg (Free subscription) | 11/03/2009
Two genes, each one of which is known to cause cancer on its own, together can lead to aggressive leukaemia. This is the conclusion from new research carried out on gene-modified mice at the Sahlgrenska Academy at the University of Gothenburg, Sweden. The discovery has surprised scientists, and may lead to new treatments.
The 3 latest articles published by users on Leukemia :
aarkstore | 10/28/2009
Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Therapy Area Pipeline Report contains detailed information on the acute lymphoblastic leukemia or leukemia or chronic lymphocytic leukemia or chronic myelogenous leukemia or acute myelogenous leukemia or hairy cell leukemia drug pipeline. This...
julieadam | 09/11/2009
The news is filled with new discoveries and benefits of stem cell therapy on a daily basis. However, as most stem cell treatments and therapies aren’t yet approved in the U.S., patients are left in a quandry when it comes to potential treatment. However, one of the most commonly performed transplants in the U.S. has been the bone marrow transplant. Since 1968, this treatment has been used to treat...
sonupt5@gmail.com | 08/26/2009
Blood Cancer | Causes of Blood Cancer | Blood Cancer Treatment Treating Leukemia, or blood cancer, requires a specialist, like Dr. Delong Liu, M.D. PhD, at Westchester Oncology and Hematology Group. Coming from Albert Einstein College of Medicine, Mt. Sinai Medical Center and Memorial Sloan Kettering Cancer Center where Dr. Liu developed broad expertise in the management of leukemia, lymphoma, aplastic
Videos